IMPROVEMENT IN BONE MINERAL DENSITY AFTER SWITCHING FROM TENOFOVIR TO ABACAVIR IN HIV-1-INFECTED PATIENTS WITH LOW BONE MINERAL DENSITY: TWO-CENTRE RANDOMIZED PILOT STUDY (OSTEOTDF STUDY).

Patrocinadores de la web
Lilly
Angelini
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter
Kyowa Kirin
Amgen